Merck Buys Peloton Therapeutics For $1.05B Ahead Of IPO
Merck said Tuesday it has agreed to snap up Peloton Therapeutics in a deal steered by Covington & Burling and Wilson Sonsini that could be worth a total of $2.2 billion...To view the full article, register now.
Already a subscriber? Click here to view full article